Study identifies potential new class of drug for treating ulcerative colitis
Oral drug shows clinical response and remission in some patients
2012-08-16
(Press-News.org) An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New England Journal of Medicine (NEJM).
Results from the phase 2 clinical trial showed the drug Tofacitinib achieved clinical response and remission in certain patients suffering from ulcerative colitis – a chronic inflammatory disease of the colon where patients experience painful episodes of rectal bleeding and diarrhea combined with the urgent need to use the restroom.
"Ulcerative colitis causes severe bouts of illness that adversely affect a patient's quality of life at home and work." said William Sandborn, MD, chief of the Division of Gastroenterology at the UC San Diego School of Medicine and director of the Inflammatory Bowel Disease Center at UC San Diego Health System. "Oral treatment with Tofacitinib resulted in improvement and remission in some patients."
Currently, there are limited types of drugs to treat ulcerative colitis. Drugs available are not universally effective and some require intravenous administration.
"This is a whole new class of drug that affects the number of proteins in the immune system that cause this type of inflammatory bowel disease (IBD)," said Sandborn.
There are about 600,000 to 700,000 patients suffering from ulcerative colitis in the United States. Half of these patients experience severe flare ups that in some cases could progress to surgery where the colon is completely removed.
"Patients with a more advanced case of ulcerative colitis need a potent and highly effective therapy," said Sandborn. "The results of our study show Tofacitinib may provide a new approach to attacking this disease."
One hundred and ninety four patients were part of the randomized trial, which was conducted at 51 centers in 17 countries. Eligible patients were at least 18 years of age, had a confirmed diagnosis of ulcerative colitis and had previously been treated with conventional therapy for the disease.
The patients were treated for eight weeks. They were given a dose of Tofacitinib twice daily, and benefits could be seen as early as two weeks. A flexile sigmoidoscopy was performed at the beginning and end of the trial, along with blood work and stool samples as a measurement of intestinal inflammation.
Among patients treated, the most commonly reported infections were influenza and nasopharyngitis - a respiratory infection with common-cold symptoms. Two patients developed an abscess, and in some cases, headaches were reported and the ulcerative colitis worsened.
"The goal of this study was to show that the oral inhibitor is effective in treating ulcerative colitis. The next phase of studies aim to confirm the efficacy and safety profile of the drug, will examine the long term or maintenance effect of Tofacitinib and confirm the results of this study," said Sandborn.
###
Researchers who also participated in this study include Subrata Ghosh, MD, University of Calgary; Julian Panes, MD, Hospital Clinic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain; Ivana Vranic, PhD, Chinyu Su, MD, Samantha Rousell, MSc, and Wojciech Niezychowski, MD, all at Pfizer Inc.
The study was funded by Pfizer Inc.
The Division of Gastroenterology at UC San Diego Health System is nationally recognized for its innovative and comprehensive care of patients by a multidisciplinary team of specialists in gastroenterology, endoscopy, oncology, surgery, transplantation and radiology.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-08-16
A previously unrecognized system that drains waste from the brain at a rapid clip has been discovered by neuroscientists at the University of Rochester Medical Center. The findings were published online August 15 in Science Translational Medicine.
The highly organized system acts like a series of pipes that piggyback on the brain's blood vessels, sort of a shadow plumbing system that seems to serve much the same function in the brain as the lymph system does in the rest of the body – to drain away waste products.
"Waste clearance is of central importance to every organ, ...
2012-08-16
CORVALLIS, Ore. – An international group of more than 30 researchers today gave a score to every coastal nation on their contribution to the health of the world's oceans, which showed the United States as being slightly above average, and identified food provision, tourism and recreation as leading concerns.
The analysis, published in the journal Nature, scored each nation on a 0-100 scale in 10 separate categories such as clean water, biodiversity, food provision, carbon storage, coastal protection, coastal economies and others.
In this "Ocean Health Index," the world ...
2012-08-16
A research team from the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, and University of Cambridge has for the first time established a link between high levels of urinary Bisphenol-A (BPA) and severe coronary artery stenosis (narrowing of the arteries).
The study is published in PLoS ONE today, 15th August 2012.
The team analysed data from 591 patients who participated in the Metabonomics and Genomics Coronary Artery Disease (MaGiCAD) study in Cambridgeshire, UK. They compared urinary BPA with grades of severity of coronary artery disease ...
2012-08-16
Sexual selection in the Forked Fungus Beetle favors larger body and horn size, and a new study investigates the relationship between these traits and the beetles' grip strength, which is crucial for the male to hold on to the female and shield her from other males in an elaborate courtship ritual. The full results are reported on Aug. 15 in the open access journal PLoS ONE.
During the courtship ritual, male beetles grab onto the female, sometime for several hours, which would seem to favor males with stronger grip. A video of this behavior is included with the published ...
2012-08-16
Given the option to commit spiteful acts, reducing the money payoffs of others at no cost to themselves, many people avoid acting spitefully, but those that do, consistently impose the maximum harm, according to research reported on Aug. 15 in the open access journal PLoS ONE.
The authors, Erik Kimbrough of Simon Fraser University in Canada and Philipp Reiss of Maastricht University in the Netherlands, created an artificial auction market scenario, with participants "bidding" for objects and having the opportunity to raise the price paid by others, to test the frequency ...
2012-08-16
Specific gut bacteria may be associated with metabolic syndrome traits, as determined by a study of Pennsylvania's Old Order Amish population. The full results are reported on Aug. 15 in the open access journal PLoS ONE.
The researchers, led by Claire M. Fraser of the Institute for Genome Sciences at the University of Maryland School of Medicine, chose the Amish as subjects for their study due to their close genetic relationships, similar lifestyles, and low prescription drug usage, among other factors, all of which reduced the number of confounders in the study and helped ...
2012-08-16
STANFORD, Calif. — One might expect that ridding a brain cell of damaged proteins would be a universally good thing, and that impairing the cell's ability to do this would allow the faulty proteins to accumulate within the cell, possibly to toxic levels. So a lot of scientific effort has gone into looking for ways to enhance the process by which cells dispose of banged-up proteins.
But this thinking may need some revision, according to a new study from the Stanford University School of Medicine. Senior author Thomas Sudhof, MD, professor of molecular and cellular physiology, ...
2012-08-16
(Santa Barbara, Calif.) –– Using a new comprehensive index designed to assess the benefits to people of healthy oceans, scientists have evaluated the ecological, social, economic, and political conditions for every coastal country in the world. Their findings, published today in the journal Nature, show that the global ocean scores 60 out of 100 overall on the Ocean Health Index. Individual country scores range widely, from 36 to 86. The highest-scoring locations included densely populated, highly developed nations such as Germany, as well as uninhabited islands, such as ...
2012-08-16
Researchers at the University of Maryland School of Medicine have identified 26 species of bacteria in the human gut microbiota that appear to be linked to obesity and related metabolic complications. These include insulin resistance, high blood sugar levels, increased blood pressure and high cholesterol, known collectively as "the metabolic syndrome," which significantly increases an individual's risk of developing diabetes, cardiovascular disease and stroke.
The results of the study, which analyzed data from the Old Order Amish in Lancaster County, Pa., are being published ...
2012-08-16
PLoS ONE announces the launch of the Synthetic Biology Collection. The new Collection contains an unprecedented number of articles illustrating the many facets of this dynamically evolving research area.
The field of synthetic biology interconnects many engineering and scientific disciplines including biology, chemical engineering, chemistry, electrical engineering, and computer science. PLoS ONE has published more than 50 articles covering all aspects of synthetic biology. The journal aims to help increase the visibility of this growing transdisciplinary field by ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study identifies potential new class of drug for treating ulcerative colitis
Oral drug shows clinical response and remission in some patients
